DrugsControl Media Services

News Detail

US FDA Expands Evinacumab Approval to Younger Kids With HoFH (23-03-2023)

Maryland, 22 March 2023: The US Food and Drug Administration has expanded the indicated age range for evinacumab-dgnb (Evkeeza, Regeneron Pharmaceuticals), which was approved 2 years ago as an adjunct to other lipid-l......
View Details

Source : Medscape
US Food and Drug Administration evinacumab-dgnb Evkeeza Regeneron Pharmaceuticals homozygous familial hypercholesterolemia HoFH)

Related News